483
InBios International, Inc.InBios International, Inc. – FDA 483, Jun 16, 2022
Record Details
An FDA inspection of InBios International, Inc. in Seattle, WA, revealed four observations related to deficiencies in their quality system. Issues included inadequate procedures for environmental condition control, supplier qualification, and customer complaint handling. Additionally, the firm's sampling plans for raw materials were found not to be based on valid statistical rationale.
View Company Profile
ID · d73d0f43-e09d-4b39-b69a-ee4e5675e327
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.